Concepedia

Publication | Closed Access

A combined lymphokine-activated killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma.

15

Citations

12

References

2014

Year

Hiroki Saito, Satoshi Ando, Naoya Morishita, Kyung‐Mi Lee, Dante Dator, David Dy, Katsumi Shigemura, Zainal Adhim, Ken‐ichi Nibu, Masato Fujisawa,
PubMed

Abstract

The combinational therapy of LAK immunotherapy and Ad-p53 gene therapy may represent a new paradigm for the treatment of head and neck cancer.

References

YearCitations

Page 1